These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. Mancia G; Parati G; Borghi C; Ghironzi G; Andriani E; Marinelli L; Valentini M; Tessari F; Ambrosioni E; J Hypertens; 2006 May; 24(5):837-43. PubMed ID: 16612244 [TBL] [Abstract][Full Text] [Related]
23. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Oladapo OO; Salako L; Sodiq O; Shoyinka K; Adedapo K; Falase AO Cardiovasc J Afr; 2010; 21(1):26-31. PubMed ID: 20224842 [TBL] [Abstract][Full Text] [Related]
24. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. Jo I; Ahn Y; Lee J; Shin KR; Lee HK; Shin C J Hypertens; 2001 Sep; 19(9):1523-32. PubMed ID: 11564970 [TBL] [Abstract][Full Text] [Related]
25. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. Joffres MR; Hamet P; Rabkin SW; Gelskey D; Hogan K; Fodor G CMAJ; 1992 Jun; 146(11):1997-2005. PubMed ID: 1596849 [TBL] [Abstract][Full Text] [Related]
26. [Prevalence of hypertension in El-Menia oasis, Algeria, and metabolic characteristics in population]. Hamida F; Atif ML; Temmar M; Chibane A; Bezzaoucha A; Bouafia MT Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):172-8. PubMed ID: 23711897 [TBL] [Abstract][Full Text] [Related]
27. Obesity is the key determinant of cardiovascular risk factors in the Hong Kong Chinese population: cross-sectional clinic-based study. Lee ZS; Critchley JA; Chan JC; Anderson PJ; Thomas GN; Ko GT; Young RP; Chan TY; Cockram CS; Tomlinson B Hong Kong Med J; 2000 Mar; 6(1):13-23. PubMed ID: 10793398 [TBL] [Abstract][Full Text] [Related]
28. Epidemiology of conventional cardiovascular risk factors among hypertensive subjects with normal and impaired fasting glucose. Akintunde AA S Afr Med J; 2010 Sep; 100(9):594-7. PubMed ID: 20822649 [TBL] [Abstract][Full Text] [Related]
29. Hypertensive waist: first step of the screening for metabolic syndrome. Nita C; Hancu N; Rusu A; Bala C; Roman G Metab Syndr Relat Disord; 2009 Apr; 7(2):105-10. PubMed ID: 19032044 [TBL] [Abstract][Full Text] [Related]
30. Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project (GEMCAS). Moebus S; Hanisch JU; Aidelsburger P; Bramlage P; Wasem J; Jöckel KH Cardiovasc Diabetol; 2007 Sep; 6():22. PubMed ID: 17822558 [TBL] [Abstract][Full Text] [Related]
31. Blood pressure levels and obesity trends in hypertensive and normotensive Finnish population from 1982 to 1997. Kastarinen MJ; Nissinen AM; Vartiainen EA; Jousilahti PJ; Korhonen HJ; Puska PM; Tuomilehto J Hypertens; 2000 Mar; 18(3):255-62. PubMed ID: 10726710 [TBL] [Abstract][Full Text] [Related]
33. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients. Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587 [TBL] [Abstract][Full Text] [Related]
34. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141 [TBL] [Abstract][Full Text] [Related]
35. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and lifestyle determinants of the metabolic syndrome. Villegas R; Creagh D; Hinchion R; O'Halloran D; Perry IJ Ir Med J; 2004; 97(10):300-3. PubMed ID: 15696875 [TBL] [Abstract][Full Text] [Related]
37. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. Fagard RH; Van Den Enden M; Leeman M; Warling X J Hypertens; 2002 Jul; 20(7):1297-302. PubMed ID: 12131525 [TBL] [Abstract][Full Text] [Related]
38. Association of hypertension with cluster of insulin resistance syndrome factors: the Chennai Urban Population Study (CUPS-12). Deepa R; Pradeepa R; Shanthirani CS; Mohan V; Acta Diabetol; 2004 Jun; 41(2):49-55. PubMed ID: 15224205 [TBL] [Abstract][Full Text] [Related]
39. Is insulin or its precursor independently associated with hypertension? An epidemiological study in Japanese-Brazilians. Ferreira SR; Franco LJ; Gimeno SG; Iochida LC; Iunes M Hypertension; 1997 Sep; 30(3 Pt 2):641-5. PubMed ID: 9322996 [TBL] [Abstract][Full Text] [Related]
40. The metabolic syndrome in Hong Kong Chinese. The interrelationships among its components analyzed by structural equation modeling. Chan JC; Cheung JC; Lau EM; Wooà J; Chan AY; Swaminathan R; Cockrama CS Diabetes Care; 1996 Sep; 19(9):953-9. PubMed ID: 8875088 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]